A six-year-old boy who has recently finished treatment for rhabdomyosarcoma is set to take part in a special fundraising event in aid of a Children's Cancer and Leukaemia Group (CCLG) Special Named Fund set up in his name.
Children's Cancer and Leukaemia Group (CCLG) hosts its annual Winter Meeting next week (April 4-5), bringing together experts from across the childhood cancer community. The UK's leading children's cancer meeting for professionals returns for a two-day conference of essential updates on...
In a statement released today (Wednesday, March 30), the One Cancer Voice charity coalition, of which Children’s Cancer and Leukaemia Group (CCLG) is a member, has published 10 tests the Government’s new ‘10-year Cancer Plan’ must meet to succeed in delivering world-leading and transformative change.
A family fundraising in memory of their five-year-old son has now raised £250,000 for research into rhabdomyosarcoma. After Jake Ellis passed away from the soft tissue cancer in 2008, his parents, Jo-ann and Nick, set up Team Jake, a Children’s Cancer and Leukaemia Group (CCLG)...
Experts from the University of Nottingham have developed a protocol for clinicians around the world which will help to close the gap between diagnosis and treatment of childhood cancer, and could increase the chance of survival from the disease.
A Hertfordshire school has raised £3,000 for Children’s Cancer and Leukaemia Group (CCLG) in support of two of its pupils undergoing treatment for cancer. Children and staff at Thundridge Primary marked World Cancer Day on February 4 by braving the elements to take on a 5K sponsored...
UK employees at World Duty Free, which is part of leading global travel retailer Dufry, have voted for Children’s Cancer and Leukaemia Group (CCLG) becoming the company’s latest charity partner.
This year, Childen's Cancer and Leukaemia Group (CCLG) is proudly celebrating its 45th anniversary.
In TYAC's ambitious strategy for 2020 - 2025, one of our aims was to lead and fund world-class research dedicated to teenage and young adult cancers. Following a hiatus due to the COVID-19 pandemic, today we're proud to launch our first research strategy to help fulfil that goal.
